Skip to content

Usability of subcutaneous COntinuous glucose MonitorING in critically ill patients

Usability of subcutaneous COntinuous glucose MonitorING in critically ill patients - UPCOMING

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37085
Enrollment
50
Registered
2012-10-03
Start date
2012-10-18
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critical illness associated hyperglycemia

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patient is at least 18 years old - Patient is admitted to the ICU of the Academic Medical Center, The Netherlands. - Patient has anticipated life expectancy greater than 96 hours - Patient has recent platelet count greater than 30,000 per micro-liter

Exclusion criteria

Exclusion criteria: - Patient currently has a suspected or diagnosed medical condition that, in the opinion of the Investigator, warrants exclusion from the study or prevents the patient from completing the study - Patient is currently participating in another investigational drug or device study - Patient is pregnant, as determined by hospital admission

Design outcomes

Primary

MeasureTime frame
The main study parameter is the accuracy of subcutaneous CGM glucose measurements.

Secondary

MeasureTime frame
The secondary endpoint of this study is to train healthcare workers to use of the Medtronic Sentrino® system, and to obtain feedback from the users on the usability of the Medtronic Sentrino® system.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)